nifedipine has been researched along with Gingival Pocket in 7 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Gingival Pocket: An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 9.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| "The purpose of this study was to examine the composition of subgingival plaque of 140 periodontal lesions in 35 patients with cardiovascular disorders who were administered nifedipine and manifested nifedipine-induced gingival overgrowth (GO)." | 7.70 | Subgingival microflora associated with nifedipine-induced gingival overgrowth. ( Andronikaki, A; Kamma, JJ; Mitsis, F; Nakou, M, 1998) |
| "In order to clarify a possible pathophysiological role of medullasin, a neutrophil elastase-like proteinase, in nifedipine (NF)-induced gingival overgrowth, the distributions of medullasin-positive cells immunostained in specimens from patients with NF-induced gingival overgrowth and chronic marginal gingivitis were compared in three different biopsy areas." | 7.69 | Possible roles of medullasin in nifedipine-induced human gingival overgrowth. ( Aoki, Y; Kato, I; Kunimatsu, K; Ozaki, Y, 1996) |
| "Treatment with either cyclosporin A or nifedipine may induce gingival hyperplasia." | 7.69 | Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. ( Babich, S; Jackson, C, 1997) |
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 5.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| "Patients taking nifedipine are at high risk for gingival enlargement, and gingivitis acts as a predisposing factor." | 3.71 | Prevalence and risk of gingival enlargement in patients treated with nifedipine. ( Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J; Roset, P, 2001) |
| "The purpose of this study was to examine the composition of subgingival plaque of 140 periodontal lesions in 35 patients with cardiovascular disorders who were administered nifedipine and manifested nifedipine-induced gingival overgrowth (GO)." | 3.70 | Subgingival microflora associated with nifedipine-induced gingival overgrowth. ( Andronikaki, A; Kamma, JJ; Mitsis, F; Nakou, M, 1998) |
| "In order to clarify a possible pathophysiological role of medullasin, a neutrophil elastase-like proteinase, in nifedipine (NF)-induced gingival overgrowth, the distributions of medullasin-positive cells immunostained in specimens from patients with NF-induced gingival overgrowth and chronic marginal gingivitis were compared in three different biopsy areas." | 3.69 | Possible roles of medullasin in nifedipine-induced human gingival overgrowth. ( Aoki, Y; Kato, I; Kunimatsu, K; Ozaki, Y, 1996) |
| "Treatment with either cyclosporin A or nifedipine may induce gingival hyperplasia." | 3.69 | Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. ( Babich, S; Jackson, C, 1997) |
| " Gingival changes in the nifedipine patients were not related to drug dosage or plaque scores." | 1.28 | The incidence and severity of nifedipine-induced gingival overgrowth. ( Barclay, S; Idle, JR; Seymour, RA; Thomason, JM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunimatsu, K | 1 |
| Ozaki, Y | 1 |
| Aoki, Y | 1 |
| Kato, I | 1 |
| Jackson, C | 1 |
| Babich, S | 1 |
| Westbrook, P | 1 |
| Bednarczyk, EM | 1 |
| Carlson, M | 1 |
| Sheehan, H | 1 |
| Bissada, NF | 1 |
| Nakou, M | 1 |
| Kamma, JJ | 1 |
| Andronikaki, A | 1 |
| Mitsis, F | 1 |
| Miranda, J | 1 |
| Brunet, L | 1 |
| Roset, P | 1 |
| Berini, L | 1 |
| Farré, M | 1 |
| Mendieta, C | 1 |
| Romanos, GE | 1 |
| Schröter-Kermani, C | 1 |
| Hinz, N | 1 |
| Bernimoulin, JP | 1 |
| Barclay, S | 1 |
| Thomason, JM | 1 |
| Idle, JR | 1 |
| Seymour, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effects of PRF, CGF and AFG Application on Wound Healing Following Gingivectomy and Gingivoplasty Operations: a Randomized Controlled Clinical Trial[NCT04805463] | 19 participants (Actual) | Interventional | 2020-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nifedipine and Gingival Pocket
| Article | Year |
|---|---|
Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
Topics: Adult; Aged; Antihypertensive Agents; Biopsy; Calcium Channel Blockers; Dental Plaque Index; Evaluat | 1997 |
6 other studies available for nifedipine and Gingival Pocket
| Article | Year |
|---|---|
Possible roles of medullasin in nifedipine-induced human gingival overgrowth.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Chronic Disease; Coloring Agents; Connecti | 1996 |
Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report.
Topics: Calcium Channel Blockers; Cyclosporine; Drug Synergism; Female; Gingival Hyperplasia; Gingival Pocke | 1997 |
Subgingival microflora associated with nifedipine-induced gingival overgrowth.
Topics: Adult; Age Factors; Aged; Bacteroidaceae; Bacteroides; Calcium Channel Blockers; Campylobacter; Capn | 1998 |
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Calcium Channel Blockers; Cross-Se | 2001 |
Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia.
Topics: Actin Cytoskeleton; Adult; Connective Tissue; Connective Tissue Cells; Cyclosporine; Dental Plaque; | 1992 |
The incidence and severity of nifedipine-induced gingival overgrowth.
Topics: Atenolol; Dental Plaque Index; Female; Gingival Hyperplasia; Gingival Pocket; Humans; Incidence; Mal | 1992 |